Sponsored Links
  • Abbott 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • VitalGo Systems 1300x380
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • Grifols 1300x380
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation
  • ODI Orthodynamics Company 1300x380
  • Medtronic 1300x380
  • EigenFlow 2 Advanced 1300x380

Outcomes for Left Ventricular Assist Device Usage with End-Stage Renal Disease

In April 2022, researchers from Queens Hospital Center (Internal Medicine), Icahn School of Medicine at Mount Sinai (Internal Medicine), Kettering Medical Center (Internal Medicine), Rawal Institute of Health Services (Medicine), Weill Cornell Medicine (Cardiology/Medicine), and Queens Hospital Center (Cardiology) examined the outcomes of end-stage renal disease (ESRD) patients requiring a left ventricular assist device (LVAD)…

Login in to view this article:

You need to be logged in to view the rest of this article. Don't have an account? Register for one below.

Notify of

Inline Feedbacks
View all comments
Sponsored Links
  • Beating Heart Newsletter Ad
  • EigenFlow 2 Advanced 800x800
  • HBP Place Ad Here

Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.

Would love your thoughts, please comment.x